Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The liposomal phospholipid bilayer is a structural assembly composed primarily of amphiphilic phospholipids arranged in a double-layered (bilayer) configuration, forming the outer shell of liposomes. Each bilayer consists of hydrophilic phosphate head groups facing outward toward aqueous environments and hydrophobic fatty acid tails oriented inward, away from water, creating a hydrophobic core. This structure enables liposomes to encapsulate hydrophilic or hydrophobic drugs, protect them from degradation, and deliver them to target tissues. The bilayer can be composed of natural or synthetic phospholipids, often stabilized by cholesterol or other sterols, and features physical properties (fluidity, permeability) dictated by the lipid composition. The principal function of the liposomal bilayer is as a vehicle or carrier for therapeutic agents rather than acting as a direct pharmacological target, receptor, enzyme, or transporter. As such, the bilayer itself is not generally considered a conventional therapeutic "target" but rather a delivery platform[3][4][5][8]. Notes on correctness: - "Liposomal phospholipid bilayer" refers to a structure, not a molecular target or receptor; it does not itself mediate biological effects as a target, but provides a vehicle for drug delivery[4][5][8]. - For structured drug-target data extraction, this entry is incorrect as a therapeutic target; it should be classified as a formulation vehicle or delivery system, not a receptor, enzyme, transporter, or other typical drug target.
Acts as a vehicle for drug delivery by encapsulating therapeutic agents and facilitating their entry into cells via fusion, endocytosis, or phagocytosis[2][4][5]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Liposomal phospholipid bilayer.